Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ghanshyam Parmar has a total of 118 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Personalized Nanocomposite-based Drug Delivery Systems: Integration of AI and 3D Printing

    by Chintan Aundhia, Ghanshyam Parmar, Chitrali Talele, Mamta Kumari, Gaurav Gupta

    Introduction: This review aims to comprehensively discuss the emerging role of artificial intelligence (AI) and three-dimensional (3D) printing in the design and development of personalized polymeric nanocomposite-based drug delivery systems. The focus is on how integrating these technologies enhances the precision, efficacy, and customization of pharmacotherapy compared with conventional formulations. Methods: An extensive literature survey was conducted using databases such as PubMed, Scopus, Web of Science, and ScienceDirect, focusing on publications from the past decade. Peer-reviewed studies, reviews, and reports on polymeric nanocomposites, AI-based formulation design, and 3Dprinted drug delivery systems were critically analyzed. The collected data were synthesized to elucidate design principles, fabrication methods, and the synergistic application of AI and 3D printing in personalized medicine. Results: Polymeric nanocomposites have demonstrated superior performance in targeted and controlled drug release due to their adaptable physicochemical properties and biocompatibility. The application of AI enables predictive modeling, optimization of formulation parameters, and patient stratification through data-driven algorithms. Concurrently, 3D printing enables the fabrication of patient-specific dosage forms and implants with programmable drug-release profiles. Together, these technologies enable the development of individualized therapeutic systems that enhance treatment outcomes and minimize adverse effects. Discussion: This synergistic incorporation of AI and additive manufacturing tackles some of the main obstacles in precision medicine by diminishing trial-and-error in formulation, enhancing reproducibility, and promoting better outcomes during treatment. Such multidisciplinary applications are most promising in cancer, diabetes, neurodegenerative, infectious, and cardiovascular diseases. Conclusion: The integration of AI and 3D printing represents a transformative advancement in personalized nanocomposite drug delivery. These interdisciplinary approaches collectively enable precise control over drug release kinetics, dosage customization, and formulation design. Future developments focusing on regulatory standardization, ethical data use, and large-scale clinical translation will further accelerate the adoption of AI- and 3D-printing-assisted personalized drug delivery systems in clinical practice. While these technologies hold great potential for personalized and precise therapeutics, their clinical translation remains challenged by regulatory validation, manufacturing reproducibility, and data transparency requirements.


  • Integrated in vitro and in silico evaluation of rutin as a potential modulator of wound healing pathways

    by Ghanshyam Parmar, Jay Mukesh Chudasama, Ashish Shah, Chintan Aundhia, Ashish Patel, Damiki Laloo, Ravi Bansal

    Wound healing is a multifactorial biological process that requires the coordinated regulation of inflammation, cell migration, angiogenesis, growth, and extracellular matrix remodeling. These drawbacks of existing wound care treatments prompt the need to seek safe and cost-effective agents and multi-target agents. This was demonstrated in a study that investigated the wound-healing capacity of a natural flavonoid glycoside, rutin, using an integrated in vitro-in silico methodology. An MTT assay was used to determine the cytocompatibility of rutin in L929 fibroblast cells, and the results showed that cell viability was high at a wide range of concentrations. A scratch wound healing assay showed enhanced fibroblast migration and wound closure in a concentration-dependent manner, and wound contraction was nearly complete within 72 h at optimum concentrations. To understand the molecular mechanisms underlying these effects, network pharmacological analysis revealed 94 common targets between rutin-associated wound healing and rutin-associated genes. Protein-protein interaction analysis identified key regulatory nodes, such as PIK3R1, PRKCA, and EGFR, which are central to the pathways that regulate cell proliferation, migration, angiogenesis, and inflammatory regulation. Enrichment analysis of gene ontology and KEGG pathways revealed that the PI3K-Akt, MAPK, VEGF, and AGE-RAGE signaling pathways were highly involved. Molecular docking showed good binding affinities of rutin to PIK3R1, PRKCA, and EGFR, which was also confirmed by 100 ns molecular dynamics simulations that revealed complex stability and favorable conformational behavior. Density functional theory analysis showed that the electronic characteristics were in line with the antioxidant activity and the strong intermolecular interactions. Together, these results demonstrate that rutin is a promising multifunctional topical wound-healing agent and provide mechanistic evidence for its use in topical therapeutic applications.

  • Open Access

    Herbal Therapies for Asthma: A Review of Traditional and Modern Perspectives

    by Sunil Kardani, Ghanshyam Parmar, Jay Chudasama, Nirmal Shah, Dipti Gohil, Rajesh Maheshwari

    This review explores the potential of nine herbal plants - Turmeric, Ginger, Black Seed, Holy Basil, Licorice, Garlic, Boswellia, Adhatoda vasica, and Ginseng in preventing and alleviating asthma symptoms. Asthma, a chronic inflammatory airway disease, often benefits from conventional treatments, but interest in natural alternatives is growing. Traditional herbal medicines show promise as alternative treatments and management strategies for asthma. Research highlights that many of these herbs exhibit anti-inflammatory, antioxidant, bronchodilatory, and immunomodulatory effects, which are crucial for addressing asthma’s underlying mechanisms. For instance, compounds like curcumin from Turmeric and thymoquinone from Black Seed have demonstrated anti-inflammatory and bronchodilatory properties. Ginger and Holy Basil have shown immunomodulatory effects that can help control airway inflammation. While current evidence often stems from in vitro, animal, or preliminary human studies, suggesting a role in symptomatic relief and potentially inhibiting disease progression, further rigorous clinical trials are needed to confirm their preventive efficacy and establish clear guidelines for their use as natural alternatives to conventional drugs, ultimately aiming to improve the quality of life for asthmatic patients. Major Finding: The review concludes that Turmeric, Ginger, Black Seed, Holy Basil, Licorice, Garlic, Boswellia, Adhatoda vasica, and Ginseng show strong potential in alleviating asthma and evidence from laboratory, animal, and limited human studies indicates they may improve airway function and reduce inflammation with therapeutic efficacy in asthma management.

  • Impact and Significance of Viral Vectors for siRNA Delivery in the Treatment of Alzheimer’s Disease

    by Chintan Aundhia, Ghanshyam Parmar, Chitrali Talele, Rahul Trivedi, Mamta Kumari, Jay Chudasama

    Alzheimer’s disease (AD) remains a major challenge in developing effective treatments due to its complex pathophysiology, including the accumulation of amyloid-beta plaques and tau tangles. Small interfering RNA (siRNA) technology offers promise for targeted gene silencing, but effective delivery to the central nervous system remains a significant obstacle. Viral vectors have emerged as potent delivery vehicles for transporting siRNA to neural tissues. This review explores the utilization of viral vectors for siRNA delivery in AD, focusing on delivery strategies and challenges. We discuss the design and optimization of viral vectors, targeting strategies, and safety considerations. Additionally, we examine recent advancements and prospects for enhancing viral vector-mediated siRNA delivery in AD.


  • Polymeric Nanocarriers with pH-Dependent Release for Tumor-Specific Delivery

    by Chintan Aundhia, Ghanshyam Parmar, Chitrali Talele, Piyushkumar Sadhu, Avinshkumar Seth

    The acidic nature of tumor microenvironments presents a unique opportunity for the targeted delivery of therapeutics using pH-responsive polymeric nanocarriers. These smart nanocarriers are designed to release their payload specifically in response to the low pH found in tumor tissues, thereby enhancing drug accumulation at the tumor site while minimizing systemic side effects. This review provides a comprehensive overview of the design principles, fabrication methods, and applications of pH-responsive polymeric nanocarriers for targeted drug delivery in tumor microenvironments. Key topics include the mechanisms of pH-responsive drug release, engineering strategies for developing pH-sensitive polymers, and recent advancements in exploiting tumor acidity for improved therapeutic outcomes. Additionally, the review discusses the clinical potential and the challenges associated with the translation of these nanocarriers from bench to bedside.


  • A combined network pharmacology and experimental approach to investigate the mechanisms of curcumin on diabetes through the adipocytokine signaling pathway

    by Ghanshyam Parmar, Jay Mukesh Chudasama, Rajesh A. Maheshwari, Denish Hinsu, Ashish Shah, Avinash K. Seth, Ramachandran Balaraman

    The present investigation aims to establish the mechanism of curcumin in targeting diabetes and obesity, specifically through its effects on Adipoq, Il-6, and Tnf-α, using network pharmacology-based in silico analysis, followed by in silico validation. Target genes associated with diabetes and obesity were identified using GeneCards and SwissTargetPrediction, revealing that curcumin modulates Adipoq, Il-6, and Tnf-α within the adipocytokine signaling pathway, suggesting a novel therapeutic mechanism. In this study, the effects of curcumin on diabetic rats were evaluated by assessing blood sugar levels (BSL), HbA1c, insulin levels, and adipocytokine expression. Diabetes was induced, and rats were treated with curcumin or pioglitazone for 4 weeks, followed by biochemical analysis. The in silico experimental findings demonstrate that curcumin is more effective than pioglitazone in managing obesity-induced diabetes by modulating the mRNA expression of adipocytokines. These results align with the predictions from in silico analysis, supporting the hypothesis that curcumin targets Adipoq, Il-6, and Tnf-α within the adipocytokine signaling pathway. This study introduces a targeted approach for diabetes management by modulating adipocytokines with curcumin. The integration of in silico analysis with in silico validation provides a comprehensive framework for developing novel therapeutic strategies against obesity-induced diabetes. Graphical abstract


  • Impact of Artificial Intelligence on Drug Development and Delivery

    by Chintan Aundhia, Ghanshyam Parmar, Chitrali Talele, Niyati Shah, Dipali Talele

    This review explores the transformative impact of AI on drug development and delivery in pharmaceutical sciences, spanning formulation design, real-time monitoring, targeted delivery, and future prospects. The rational design of smart drug carriers, such as AI-optimized liposomes for cancer therapy, optimizes formulations for individual patient needs. AI-driven sensors, exemplified by glucose-monitoring biosensors for diabetics, enable adaptive drug administration, enhancing precision. Despite promises, challenges like biocompatibility, regulations, and ethics persist. Interdisciplinary collaboration and transparent communication are crucial for responsible AI adoption. Anticipated trends include personalized dosage optimization and intelligent nanocarriers. The review underscores AI's potential in reshaping pharmaceuticals for patient-centric care while addressing challenges for widespread adoption.


  • Weaving the Future of Topical Medicine: A Journey with Electrospinning Nanofibre Scaffolds

    by Ghanshyam Parmar, Jay Mukesh Chudasama, Chintan Aundhia

    The pharmaceutical sciences are gradually shielding mankind from a plethora of deadly but as-of-yet-undiscovered ailments. Many diseases, some of which can be fatal, have their initial line of defence on the skin. A significant challenge for scientists is the development of appropriate pharmacological formulations for transdermal drug administration. Low side effect risk reduces first-pass impact, and good patient compliance makes transdermal distribution superior to oral delivery. This is why transdermal medication delivery is so important. Thanks to advancements in pharmaceutical delivery systems, the skin can now absorb medications more effectively. Researchers from different parts of the globe have investigated many different kinds of medications as possible transdermal delivery routes using electrospinning nanofibres. The skin can more easily absorb therapeutic compounds thanks to the nanofibres' ability to concentrate them. It is possible to load hydrophilic and lipophilic medications onto polymeric nanofibres. Another option is the transdermal distribution of biopolymer nanofibres. Over long periods of time, they control the release of medicinal substances. Nanofibres and nanoparticles allow for the controlled release of both hydrophobic and hydrophilic drugs. Transdermal and topical medication delivery using polymeric electrospinning nanofibres laden with nanoparticles and medicines is the subject of this research review. After that, we'll look at some practical instances of engineers using electrospinning fibres to control the release of drugs in reaction to environmental and internal factors. Afterwards, we will quickly go over the latest developments in tissue engineering, hard tissue engineering (which includes repairing musculoskeletal systems, bones, and cartilage), and cancer therapy that uses electrospin nanofiber scaffolds to control the distribution of drugs. Thanks to recent advancements in medicine and pharmaceuticals, nanofibres may soon be able to transport a wide variety of drugs, allowing for more targeted methods of cellular regeneration and topical medication delivery.


  • Radioactive Waste Management in a Hospital

    by Chintan Aundhia, Ghanshyam Ratilal Parmar, Chitrali Talele, Dipali Talele, AvinashKumar Seth

    Due to its toxicity, radioactive waste disposal poses environmental and public health risks. To reduce environmental contamination and human radiation exposure, radioactive waste management and disposal systems have been developed. Current nuclear waste disposal methods are covered in the chapter. Nuclear waste is disposed away in a suitable facility without return. This concludes nuclear waste handling. Baselined on radioactive waste management goals, the International Atomic Energy Agency devised a classification system. Radiotoxicity of nuclear waste predicts retention times for safe radionuclide isolation. Disposal facilities often use an engineered barrier system and a natural geological barrier to keep garbage out of the biosphere. Possible disposal sites include trenches, vaults, passages, shafts, boreholes, and mining repositories. A graded system links disposal facility site size to hazard. The disposal methods show that nuclear waste may be disposed of securely and with few environmental or health risks.